HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Abstract
TGF-beta-activated kinase 1 (TAK1), a member of the MAPKKK family, is thought to be a key modulator of the inducible transcription factors NF-kappaB and AP-1 and, therefore, plays a crucial role in regulating the genes that mediate inflammation. Although in vitro biochemical studies have revealed the existence of a TAK1 complex, which includes TAK1 and the adapter proteins TAB1 and TAB2, it remains unclear which members of this complex are essential for signaling. To analyze the function of TAK1 in vivo, we have deleted the Tak1 gene in mice, with the resulting phenotype being early embryonic lethality. Using embryonic fibroblasts lacking TAK1, TAB1, or TAB2, we have found that TNFR1, IL-1R, TLR3, and TLR4-mediated NF-kappaB and AP-1 activation are severely impaired in Tak1(m/m) cells, but they are normal in Tab1(-/-) and Tab2(-/-) cells. In addition, Tak1(m/m) cells are highly sensitive to TNF-induced apoptosis. TAK1 mediates IKK activation in TNF-alpha and IL-1 signaling pathways, where it functions downstream of RIP1-TRAF2 and MyD88-IRAK1-TRAF6, respectively. However, TAK1 is not required for NF-kappaB activation through the alternative pathway following LT-beta signaling. In the TGF-beta signaling pathway, TAK1 deletion leads to impaired NF-kappaB and c-Jun N-terminal kinase (JNK) activation without impacting Smad2 activation or TGF-beta-induced gene expression. Therefore, our studies suggests that TAK1 acts as an upstream activating kinase for IKKbeta and JNK, but not IKKalpha, revealing an unexpectedly specific role of TAK1 in inflammatory signaling pathways.
AuthorsJae-Hyuck Shim, Changchun Xiao, Amber E Paschal, Shannon T Bailey, Ping Rao, Matthew S Hayden, Ki-Young Lee, Crystal Bussey, Michael Steckel, Nobuyuki Tanaka, Gen Yamada, Shizuo Akira, Kunihiro Matsumoto, Sankar Ghosh
JournalGenes & development (Genes Dev) Vol. 19 Issue 22 Pg. 2668-81 (Nov 15 2005) ISSN: 0890-9369 [Print] United States
PMID16260493 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Antigens, Differentiation
  • GTPase-Activating Proteins
  • Interleukin-1
  • Intracellular Signaling Peptides and Proteins
  • MYD88 protein, human
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Ralbp1 protein, mouse
  • Receptors, Immunologic
  • TAB1 protein, MAPKKK activator, vertebrate
  • TNF Receptor-Associated Factor 2
  • TNF Receptor-Associated Factor 6
  • Toll-Like Receptors
  • Transcription Factor AP-1
  • Tumor Necrosis Factor-alpha
  • Protein Kinases
  • IRAK1 protein, human
  • Interleukin-1 Receptor-Associated Kinases
  • Irak1 protein, mouse
  • I-kappa B Kinase
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7
Topics
  • Adaptor Proteins, Signal Transducing (physiology)
  • Animals
  • Antigens, Differentiation (physiology)
  • Apoptosis (physiology)
  • COS Cells
  • Cell Line
  • Cell Line, Transformed
  • Chlorocebus aethiops
  • GTPase-Activating Proteins (physiology)
  • Humans
  • I-kappa B Kinase (physiology)
  • Interleukin-1 (metabolism)
  • Interleukin-1 Receptor-Associated Kinases
  • Intracellular Signaling Peptides and Proteins (physiology)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • MAP Kinase Kinase Kinases (genetics, physiology)
  • Mice
  • Mutation
  • Myeloid Differentiation Factor 88
  • NF-kappa B (metabolism)
  • Protein Kinases (physiology)
  • Receptors, Immunologic (physiology)
  • Signal Transduction (physiology)
  • TNF Receptor-Associated Factor 2 (physiology)
  • TNF Receptor-Associated Factor 6 (physiology)
  • Toll-Like Receptors (physiology)
  • Transcription Factor AP-1 (physiology)
  • Tumor Necrosis Factor-alpha (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: